LYEL

Lyell Immunopharma, Inc. $11.04 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.3%
Next 1 week
+0.1%
Next 1 month
+3.5%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 64
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.13%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.44 +3.5%
$1M/day volume 80% volatility -34% 1-year
52-week range · 10% of the way up · -76% from the high
$7.20$45.00

Earnings Full history →

Next report 2026-11-06 (Friday, after close, in 5 days) · EPS est. -1.88.

1-day std dev
7.4%
Finished up
57%
Biggest pop
+11.6%
Biggest drop
-18.6%

Standard deviation of the close-to-close move over the last 21 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-06 beat -1.79 -1.74 +2.9% -1.5% +3.5% -1.8%
2026-05-06 beat -2.36 -1.10 +53.5% +1.8% -3.8% -8.8%
2026-03-12 miss -2.23 -7.68 -244.1% +0.0% -14.2% -22.8%
2025-11-12 beat -2.64 -2.13 +19.4% -3.6% -1.2% -1.1%
2025-08-12 beat -3.58 -2.89 +19.4% -12.2% +2.5% +0.8%
2025-05-13 -3.60 -3.60 — -0.7% -3.7% +1.2%
2025-03-11 miss -2.60 -3.44 -32.4% +2.1% +0.9% -12.6%
2024-11-07 beat -4.00 -3.40 +15.0% +3.3% +0.0% -9.8%
2024-08-07 beat -4.10 -3.60 +12.2% -0.7% +6.4% -11.0%
2024-05-06 beat -3.60 -2.96 +17.8% -0.8% +7.6% +1.7%
2024-02-28 beat -4.10 -3.47 +15.3% -3.5% +2.8% -11.3%
2023-11-07 beat -4.60 -3.43 +25.5% -0.9% +4.4% -8.9%
2023-08-08 beat -4.50 -3.65 +18.9% +0.0% -0.4% -6.2%
2023-05-04 beat -4.40 -3.59 +18.4% +5.0% +2.5% +4.1%
2023-02-28 beat -5.30 -0.02 +99.7% +1.9% +11.6% -4.2%
2022-11-08 beat -6.60 -3.52 +46.7% -2.2% -18.6% -18.8%
2022-08-04 beat -5.50 -0.84 +84.8% -1.1% +9.3% +9.9%
2022-05-10 beat -5.20 -4.09 +21.3% -0.4% -11.0% -27.7%
2022-03-29 beat -5.41 -0.65 +87.9% -1.3% +3.3% +0.2%
2021-11-12 beat -10.37 -2.98 +71.2% +0.0% -1.1% -6.2%
2021-08-12 miss -17.40 -17.83 -2.5% +0.4% +3.7% +6.0%

Not investment advice.